ARCHIVES

NCI Told It Needs Overview Of Basic Research For Visibility And To Pursue Breakthroughs

This article is from The Cancer Letter archive.

Vol. 04 No. 28 | July 14, 1978

Download PDF Visit The Full Archive

Related Articles

Cancer Groups In Campaign To Draft Pazdur For FDA.

March 2, 2001

FDA Approves Erbitux for Head & Neck Cancer.

March 3, 2006

St. Jude, Washington University Plan $65 Million Pediatric Cancer Genome Project

January 29, 2010

NCAB Approves CIS Recompetition, Restructuring

May 17, 1991

In Brief: Peck Joins GenPharm board; Dallas Hospital Selects director For New BMT Program

February 11, 1994

NCA Urges Pay Line Adjustment To Cut Back On Grant Duplications

October 10, 1980